Cancer cells often invade different tissues by forming rounded protrusions called blebs. However, the exact mechanism behind ...
A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the ...
Japanese patient cohort enrollment is completed ahead of schedule at multiple clinical sites including the National Cancer Center in Tokyo The incidence rate of never-smokers with non-small cell lung ...
COPENHAGEN, Denmark--(BUSINESS WIRE)-- Genmab A/S (Nasdaq: GMAB) today announced that the Japan Ministry of Health, Labour and Welfare has approved TIVDAK® (tisotumab vedotin) for the treatment of ...
Management expressed confidence in continued growth in Japan and the U.S., emphasizing the innovative appeal of their new cancer products. Amos mentioned that the company is taking action to reinforce ...
TOKYO--(BUSINESS WIRE)-- Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz ® (retifanlimab) in combination with carboplatin and ...
The health ministry has released for the first time five-year survival rates for new cancer patients by cancer type that are based on data from Japan’s national registry. According to the data on some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results